It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Briefly: today, several people have asked for my response to this story in the Guardian, celebrating GSK’s promise for more transparency on their trial data.It is always good to hear a drug company making promises, and I hope that GSK will stick by the commitments they have made today.
But we should judge drug companies by their actions, not by their promises, especially when similar promises have been made in the past, and then broken.
GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world's fourth-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis, and Sanofi). It was established in 2000 by the merger of Glaxo Wellcome plc (formed from the acquisition of Wellcome plc by Glaxo plc) and SmithKline Beecham plc (formed from the merger of Beecham plc and SmithKline Beckman Corporation, which was formed by combining the Smith Kline French and Beckman companies).
GSK has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes, and digestive conditions. It also has a large consumer healthcare division which produces and markets oral healthcare and nutritional products and over-the-counter medicines including Sensodyne, Boost, Horlicks, and Gaviscon. In July 2012, GSK pleaded guilty to criminal charges and agreed to a $3 billion settlement of the largest health-care fraud case in the U.S. and the largest payment by a drug company in the US. The settlement is related to the company's illegal promotion of best-selling anti-depressants and its failure to report safety data about a top diabetes drug.
GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of 6 July 2012, it had a market capitalisation of £74.8 billion, the fifth-largest of any company listed on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange.
ACWY Vax Meningococcal polysaccharides serogroups A, C, W135 and Y
Ambirix Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Boostrix tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed
Cervarix Human Papillomavirus vaccine (types 16, 18) - recombinant, adjuvanted, adsorbed
Engerix-B Hepatitis B Vaccine (Recombinant)
Fendrix Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
Fluarix Influenza vaccine
FluLaval Influenza vaccine
Havrix Hepatitis A vaccine, inactivated
Hepatyrix Hepatitis A (inactivated, adsorbed) and Typhoid Polysaccharide vaccine
Hiberix haemophilus B conjugate vaccine (tetanus toxoid conjugate)
Infanrix diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed
Infanrix IPV diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
Kinrix diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Menhibrix meningococcal groups C and Y and haemophilus b tetanus toxoid conjugate vaccine
Menitorix combined Haemophilus influenzae type b and Neisseria meningitidis group C (Hib-MenC) conjugate vaccines
Nimenrix meningococcal group A, C, W-135 and Y conjugate vaccine
Pandemrix influenza vaccine (split virion, inactivated)
Pediarix diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined
Priorix measles, mumps and rubella vaccine (live attenuated virus)
Rotarix human rotavirus vaccine, live attenuated
Synflorix Pneumococcal polysaccharide conjugate vaccine (adsorbed)
Twinrix combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)
Typherix typhoid vaccine (purified polysaccharide antigen)
Varilrix varicella in healthy adults and adolescents